Objective: To evaluate the in vitro polymerization shrinkage resistance and in vivo tissue response of the resin-modified glass ionomer cement (RMGIC) Ketac N100 after implantation in the subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback